Dr. Wael Khreisat | Pediatric Neurology – Royal Medical Services, Jordan
Dr. Wael Hayel Khreisat is a distinguished pediatric neurologist and educator with over three decades of experience in pediatrics and neurology. Currently serving as the Head of the Pediatric Department at the Royal Medical Services in Jordan, he has made significant contributions to pediatric neurology through clinical excellence, research, and teaching. His expertise spans pediatric epilepsy, neuromuscular disorders, CNS infections, and EEG diagnostics. A passionate educator and examiner, Dr. Khreisat is deeply committed to advancing pediatric neurology in Jordan and beyond.
Profile Verification
ORCID | SCOPUS
Education
Dr. Khreisat earned his M.B.B.S. in 1991 from the School of Medicine at the University of Salah Al-Deen, Iraq. He completed his residency in pediatrics at King Hussein Medical Center, Amman, Jordan, in 1997. In 1999, he obtained the Jordanian Board of Pediatrics and, later in 2018, the Jordanian Board of Pediatric Neurology. His postdoctoral training includes prestigious programs at Rochester Hospital, New York, and Pittsburgh Children’s Hospital, Pennsylvania, focusing on pediatric neurology.
Experience
Dr. Khreisat has held various esteemed roles in his career, including Chair of Pediatric Neurology and Neurophysiology at Queen Rania Hospital for Children. He has been a consultant pediatric neurologist at King Hussein Medical Center since 2011 and has led numerous departments and committees. His international experience includes serving as a visiting pediatric neurologist in the U.S. and working in humanitarian missions with the United Nations. Dr. Khreisat’s dedication to education is evident through his roles as a teacher and examiner at multiple universities in Jordan, where he has shaped the future of medical professionals.
Research Interests
Dr. Khreisat’s research focuses on pediatric epilepsy, pharmacogenomics, and the genetic factors influencing neurological disorders. He is particularly interested in the responsiveness of antiepileptic drugs in pediatric populations and the role of genetic polymorphisms in epilepsy susceptibility. His work also explores innovative treatments for ADHD symptoms in children with autism spectrum disorder.
Awards
Dr. Khreisat’s exceptional service has been recognized through numerous awards and accolades. His contributions to pediatric neurology and education have made him a respected figure in Jordan and internationally. He continues to lead advancements in pediatric healthcare with dedication and excellence.
Publications
📚 “Atomoxetine Treatment of ADHD in Autism Spectrum Disorder” (2024) – Published in Children (Basel), this study explores the efficacy of Atomoxetine in young children with autism.
📚 “Genetic Polymorphisms and Epilepsy Susceptibility” (2019) – Published in Pharmgenomics Pers Med, this research examines the role of CYP3A5 and CHRM2 genes in epilepsy.
📚 “Pediatric Adherence to Antiepileptic Drugs” (2022) – Published in J Pharm Technol, this paper highlights the clinical pharmacist’s role in improving adherence.
📚 “Potassium Channel Gene Polymorphisms and Epilepsy” (2018) – Published in J Pers Med, this study investigates genetic influences on antiepileptic drug responsiveness.
📚 “Factors Affecting Antiepileptic Treatment in Pediatrics” (2020) – A study exploring the predictors of drug efficacy in Jordanian children.
📚 “Gene Polymorphisms and Antiepileptic Drug Responsiveness” (2019) – Published in Pharmgenomics Pers Med, focusing on MTHFR and ABCC2 genes.
📚 “Clinical Profile of Infants with Hypsarrhythmia” (2011) – Published in Acta Inform Med, this study examines infants with severe epileptic syndromes.
Conclusion
Dr. Wael Hayel Khreisat exemplifies excellence in pediatric neurology, combining clinical practice, research, and education. His leadership in advancing pediatric healthcare and his dedication to research make him a deserving candidate for any recognition of his outstanding contributions to medicine. Dr. Khreisat continues to inspire and mentor the next generation of medical professionals while providing exceptional care to his patients.